Hess Midstream Partners LP Aktie News

Hess Midstream LP (HESM) Q4 2025 Earnings Call Transcript

HOUSTON--(BUSINESS WIRE)---- $HESM--Hess Midstream LP (NYSE: HESM) (“Hess Midstream” or the “Company”) today reported fourth quarter 2025 net income of $168.0 million compared with net income of $172.1 million for the fourth quarter of 2024. After deduction for noncontrolling interests, net income attributable to Hess Midstream was $93.3 million, or $0.72 basic earnings per Class A share, compa...

Hess Midstream LP is reiterated as a buy, supported by resilient performance, robust fundamentals, and a reasonable valuation. HESM's fee-based, long-term contracts with minimum volume commitments drive predictable revenues and shield against spot rate risks. Strategic exposure to natural gas, growing third-party revenues, and prudent debt management underpin sustainability and dividend longevity.

Delek Logistics Partners extended its distribution growth streak to 52 consecutive quarters. Hess Midstream expects to deliver at least 5% annual dividend growth through 2028.

HOUSTON--(BUSINESS WIRE)---- $HESM--HESS MIDSTREAM LP ANNOUNCES DISTRIBUTION PER SHARE LEVEL INCREASE.

Midstream MLPs offer high single-digit yields with strong defensive characteristics, making them attractive for retirement income portfolios. The yield-to-risk ratio in MLPs is compelling, even compared to my other favorite yield plays such as BDCs, covered call, and leveraged CEFs. In the article I elaborate on two highest-yielding MLPs, which are de-risked enough to meet the durable income cr...

Hess Midstream LP offers an attractive 8.8% yield with a C-corp structure, minimizing tax complexity for investors. HESM's near-term cash flows are protected by Minimum Volume Commitments with Chevron through 2028, limiting direct commodity exposure. Significant long-term risk arises if oil prices fall below $50, potentially prompting Chevron to scale back Bakken drilling post-2028.

The market is reacting to headlines, not fundamentals. Deep discounts are creating unusually asymmetric setups in quality dividend growth stocks. Patient income investors may be getting a rare gift to lock in big yields with strong dividend growth profiles.